Lamisil
NDC Package 0067-6296-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Lamisil is a medication used to treat a variety of fungal skin infections such as ringworm, athlete's foot, and jock itch. Marketed by Haleon Us Holdings Llc, this product is identified by NDC 0067-6296 and is authorized under FDA application NDA021124.

Identification & Billing

NDC Package Code
0067-6296-01
Package Description
125 mL in 1 CAN
Product Code
0067-6296
11-Digit Billing Format
00067629601

Clinical Specifications

Proprietary Name
Lamisil AT
Dosage Form
-
Usage Information
This medication is used to treat a variety of fungal skin infections such as ringworm, athlete's foot, and jock itch. This medication is also used to treat a skin condition known as pityriasis (tinea versicolor), a fungal infection that causes a lightening or darkening of the skin of the neck, chest, arms, or legs. Terbinafine is an antifungal that works by preventing the growth of fungus.

Regulatory & Marketing

Labeler Name
Haleon Us Holdings Llc
FDA Application #
NDA021124
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
03-07-2018
End Marketing Date
11-30-2022
Listing Expiration
11-30-2022
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0067-6296-01 identifies a specific commercial package of 125 ml in 1 can of Lamisil AT, labeled by Haleon Us Holdings Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Haleon Us Holdings Llc on March 07, 2018. The current certification is valid through November 30, 2022.

What are the primary indications for this medication?

This medication is used to treat a variety of fungal skin infections such as ringworm, athlete's foot, and jock itch. This medication is also used to treat a skin condition known as pityriasis (tinea versicolor), a fungal infection that causes a lightening or darkening of the skin of the neck, chest, arms, or legs. Terbinafine is an antifungal that works by preventing the growth of fungus.

How is this Haleon Us Holdings Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00067629601. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0067-6296-01
11-Digit CMS (5-4-2)
00067-6296-01

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.